The Reims University Hospital Center (CHU) takes care of the most complex pathologies across the Champagne-Ardenne region (cardiac surgery, kidney transplants, pediatric emergencies and SMURs, etc.). The URCA and the CHU have signed a university hospital agreement in order to ensure the consistency of their respective research strategies by favoring the pooling and optimization of the use of their resources. It relates in particular to the biomedical research policy of the URCA and the modalities of its deployment within the CHU as well as the modalities of participation of the CHU in university and postgraduate education. A Steering Committee common to the URCA and the CHU is in charge of implementing the commitments made under this agreement. This URCA-CHU collaboration has made it possible to develop translational research by funding three Joint Hospital-University research projects (PHU): Protein and Vascular Aging (VIVA) Research and innovation in inflammatory respiratory pathology (RINNOPARI) Social cognition and neurodevelopmental diseases (Ndev-X)
Recherche et innovation au CHU
Convention CHU-URCA
CHU acteur du réseau d'Etablissements
The Jean Godinot Institute (IJG) is the Center de Lutte Contre le Cancer (CLCC) of Reims, Champagne-Ardenne and Sud de l'Aisne dedicated exclusively to the treatment of cancerous pathologies in the Champagne region. The IJG carries out university hospital missions: care, research, teaching and prevention. The URCA and the IJG have developed their cooperation and partnerships with the aim of pooling their expertise and skills. Jean Godinot Institute Insitut Godinot actor of the network of establishments The URCA, the CHU and the IJG have thus jointly created an immunology research team (EA7509) within which the researchers have also developed work in dermatology and ophthalmology.